Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Metabolic abnormalities in lymphoma.

Fernando Cabanillas1

  • 1Centro de Cancer Auxilio Mutuo, San Juan, Puerto Rico. cabanillas@auxilio.com

Clinical Lymphoma
|January 11, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy and Safety of Denileukin Diftitox-Cxdl, an Improved Purity Formulation of Denileukin Diftitox, in Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2024
Same author

Clinical Features and Therapeutic Outcomes Comparing Primary Mediastinal Large B-cell Lymphoma to Mediastinal Hodgkin Disease.

Puerto Rico health sciences journal·2024
Same author

An Unexpected Presentation of a Maxillary Non-Hodgkin Lymphoma in an Elderly Hispanic Patient.

Puerto Rico health sciences journal·2023
Same author

Single-Arm, Open-Label Phase 2 Trial of Preemptive Methylprednisolone to Avert Progression to Respiratory Failure in High-Risk Patients with COVID-19.

medRxiv : the preprint server for health sciences·2021
Same author

Home-based management of COVID-19 by identification of low-risk features.

medRxiv : the preprint server for health sciences·2021
Same author

Prevalence of Complementary/Alternative Medicine use in Cancer Patients in a Tertiary Hospital in Puerto Rico.

Puerto Rico health sciences journal·2020

Metabolic abnormalities are common in lymphoma patients receiving chemotherapy, potentially causing kidney failure. Prompt identification and management of these electrolyte imbalances are crucial for patient outcomes.

Area of Science:

  • Oncology
  • Nephrology
  • Endocrinology

Background:

  • Chemotherapy for lymphoma frequently leads to metabolic derangements.
  • Common abnormalities include electrolyte imbalances and hyperuricemia.

Observation:

  • Tumor lysis syndrome (TLS) is a critical complication causing severe metabolic disturbances.
  • These metabolic issues can precipitate acute kidney injury.

Findings:

  • A range of metabolic abnormalities, including hypercalcemia, hyperkalemia, and hyponatremia, are observed.
  • Early detection of these imbalances is key to preventing severe complications.

Implications:

  • Implementing guidelines for early detection and management improves patient prognosis.

Related Experiment Videos

  • Proactive monitoring and intervention can mitigate risks associated with chemotherapy-induced metabolic abnormalities.